Complement activation and complement receptors in systemic lupus erythematosus - PubMed (original) (raw)

Review

Complement activation and complement receptors in systemic lupus erythematosus

J P Atkinson. Springer Semin Immunopathol. 1986.

No abstract available

PubMed Disclaimer

Similar articles

• Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus.
  Speirs C, Fielder AH, Chapel H, Davey NJ, Batchelor JR. Speirs C, et al. Lancet. 1989 Apr 29;1(8644):922-4. doi: 10.1016/s0140-6736(89)92506-3. Lancet. 1989. PMID: 2565418
• Serum complement activation of SLE patients during plasmapheresis.
  Csipö I, Kávai M, Kiss E, Bedö Z, Csongor J, Szegedi G, Philbert F, Cohen JH. Csipö I, et al. Autoimmunity. 1997;25(3):139-46. doi: 10.3109/08916939709008020. Autoimmunity. 1997. PMID: 9272279
• Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
  Fielder AH, Walport MJ, Batchelor JR, Rynes RI, Black CM, Dodi IA, Hughes GR. Fielder AH, et al. Br Med J (Clin Res Ed). 1983 Feb 5;286(6363):425-8. doi: 10.1136/bmj.286.6363.425. Br Med J (Clin Res Ed). 1983. PMID: 6401549 Free PMC article.
• The human C3b receptor: function and role in human diseases.
  Tausk F, Gigli I. Tausk F, et al. J Invest Dermatol. 1990 Jun;94(6 Suppl):141S-145S. doi: 10.1111/1523-1747.ep12876125. J Invest Dermatol. 1990. PMID: 2141047 Review.
• Immune complex clearance by complement receptor type 1 in SLE.
  Kavai M. Kavai M. Autoimmun Rev. 2008 Dec;8(2):160-4. doi: 10.1016/j.autrev.2008.06.002. Epub 2008 Jul 3. Autoimmun Rev. 2008. PMID: 18602499 Review.

Cited by

• Restricted junctional diversity of T cell receptor delta gene rearrangements expressed in systemic lupus erythematosus (SLE) patients.
  Olive C, Gatenby PA, Serjeantson SW. Olive C, et al. Clin Exp Immunol. 1994 Sep;97(3):430-8. doi: 10.1111/j.1365-2249.1994.tb06106.x. Clin Exp Immunol. 1994. PMID: 8082298 Free PMC article.
• Development and Optimization of an ELISA to Quantitate C3(H 2 O) as a Marker of Human Disease.
  Elvington M, Liszewski MK, Liszewski AR, Kulkarni HS, Hachem RR, Mohanakumar T, Kim AHJ, Atkinson JP. Elvington M, et al. Front Immunol. 2019 Apr 4;10:703. doi: 10.3389/fimmu.2019.00703. eCollection 2019. Front Immunol. 2019. PMID: 31019515 Free PMC article.
• Resveratrol Role in Autoimmune Disease-A Mini-Review.
  Oliveira ALB, Monteiro VVS, Navegantes-Lima KC, Reis JF, Gomes RS, Rodrigues DVS, Gaspar SLF, Monteiro MC. Oliveira ALB, et al. Nutrients. 2017 Dec 1;9(12):1306. doi: 10.3390/nu9121306. Nutrients. 2017. PMID: 29194364 Free PMC article. Review.
• Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
  Kim AHJ, Strand V, Sen DP, Fu Q, Mathis NL, Schmidt MJ, Bruchas RR, Staten NR, Olson PK, Stiening CM, Atkinson JP. Kim AHJ, et al. Arthritis Rheumatol. 2019 Mar;71(3):420-430. doi: 10.1002/art.40747. Epub 2019 Jan 24. Arthritis Rheumatol. 2019. PMID: 30294950 Free PMC article.
• In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.
  Kimberly RP, Edberg JC, Merriam LT, Clarkson SB, Unkeless JC, Taylor RP. Kimberly RP, et al. J Clin Invest. 1989 Sep;84(3):962-70. doi: 10.1172/JCI114259. J Clin Invest. 1989. PMID: 2527255 Free PMC article.

References

1. 1. Medicine (Baltimore). 1981 May;60(3):208-17 - PubMed
2. 1. Immunol Today. 1983 Sep;4(9):250-2 - PubMed
3. 1. J Clin Invest. 1985 Jul;76(1):182-90 - PubMed
4. 1. J Lab Clin Med. 1951 May;37(5):698-702 - PubMed
5. 1. Arthritis Rheum. 1983 Oct;26(10):1279-82 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information